chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No fever during the day post shot, no fever @ bed time; woke up 1130PM began running thought the house saying bed was on fire & brother's bed was on fire, screaming that frogs were p/him; when mom touched pt was hot; t106.5 ax; didn't eat;
This is a spontaneous report from a contactable physician. This report was received via a Pfizer sales representative. This Physician reported similar events for 3 patients. This is 2nd of 3 reports. A patient of unspecified age and gender received TRUMENBA, (lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The physician reported 3 kids (including the patient) last 2 years; patient reported flu-like symptoms with high fevers after the use of meningococcal group b rlp2086. No other vaccine given at the time. Some went to the ER and were diagnosed with having vaccine reaction. The outcome of the events, flu-like symptoms and high fevers, was unknown. No follow-up attempts are possible; information about batch number cannot be obtained. Sender's Comments: Linked Report(s): US-PFIZER INC-2018325368 Same reporter and suspect drug, similar events in different patients; US-PFIZER INC-2018325374 Same reporter and suspect drug, similar events in different patients.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 15-NOV-2011, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided) at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 25-APR-2015, the patient was treated for the onset of a severe vesicular rash, which was diagnosed as herpes zoster, or shingles. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Nausea, vomiting, severe headache, visual disturbances, severe muscle and joint aches, fever, chills, loose stools, dizziness, light sensitivity, dehydration, audible hypersensitivity,  fatigue, tremors (2 weeks on the tremors), grasp in right hand is weak and continues on.  Unable to eat or drink.  Majority of symptoms lasted 4 days.  Muscle aches and pains continue.  Sees Medical doctor.
Low grade fever, loss of appetite, vomiting/upset stomach , extreme fussiness. Three days so far.
Information has been received from a 24 year old female patient via a company representative concerning herself who became pregnant (which was captured as Maternal exposure timing unspecified) with Last Menstrual Period (LMP) of 26-MAR-2015 and expected date of delivery (EDD) of 31-DEC-2015. No pertinent medical history was reported. On an unknown date, the patient was vaccinated with GARDASIL (strength, dose, route, lot# and expiration date unknown). No concomitant therapy was reported. On 13-APR-2015 the patient experienced adverse event while on GARDASIL. No treatment was given for this event. The patient did not seek medical attention. The outcome of adverse event was unknown. The pregnant outcome was pending. Additional information is not expected since there is no contact information.
pt reported to clinic clerk that lt arm became very swollen, reddened, w/heat & sore approx 2 days p/vax;pt also reports red streaks radiating from inj site to mid elbow;tenderness lasted approx 1wk;pt did not seek eval from PMD:
Pt. states  gradually  experiencing severe nausea getting worse each day causing problem eating .  Pt. concerned regarding symptom because they are prolonged and worsening.  Pt. states due to ALS and other conditions needs to eat to to keep weight up .
The day after receiving the vaccine I woke up with slight soreness of the arm. At work at 10:00am I began to get fatigued chills overall body aches but was afebrile. I also had nasal congestion and sneezing for 4 hrs. that resolved. At 12 noon I felt progressively worse and had to leave work. I got home and my temp was 100.2 and took more Ibuprofen at 1 PM. At 2PM the body aches and chills were pretty severe- my temp rose to 103.2. I took more Ibuprofen and alternated with TYLENOL and it returned to normal at 10 PM. I notified my Drs office and had a telemedicine visit with Dr at 4PM who thought it was a normal immune response but suggested getting a COVID Test in the meantime before returning to work. I woke up this morning afebrile with no issues notified employee health got a referral and had my COVID test completed at 09:30am. The urgent care MD strongly urged me to report to VAERS, not just CDC as I had yesterday. My COVID tests are still pending.
tingling of the lips, itching all over--about 20 minutes after the vaccine; gave 1 dose of adult epi-pen, called 911- paramedics came and took blood pressure and pulse/assessed patient, mom refused hospital visit offer and patient and mother left to go home
Pain in arm a few days, then fatigue set in, then worse fatigue, then flu-like pain, for several days, then arms and legs felt heavy and lymph nodes painful everywhere all over my body, then shakiness, severe pain behind my neck/shoulders/back, legs feel like lead, arms lead, fuzzy feeling in my head because my arms and legs won't work properly, pain, just pain everywhere, fatigue and can't move. Mostly the pain is the worst part of it. Pulsating feeling in my lymph nodes and all over my body. It's been three weeks since vaccination and it's only gotten worse.
Brought in by the family for an unknown amt of time and was also diagnosed w bacteremia and uti, likely urosepsis causing cardiac arrest that led to anoxic brain injury due to unknown down time, the family made the pt comfort care and she passed away
High fever, body aches, chills, nausea, and head ache. I went to bed Friday night after getting my vaccine Friday morning. I felt perfectly fine that night, but woke up at 2 am feeling all of those symptoms. I went back to bed shivering. I woke up again at around 4 am and took some Nyquil and drank a lot of water and was able to fall back asleep. I spent the rest of Saturday in and out of sleep with a low fever and feeling spacey and woke up Sunday feeling completely fine. I had COVID-19 in July and the symptoms I experienced in the early hours Saturday felt very similar.
began feeling ill on 20OCT95 & was adm to hosp on Saturday & was there for 1 1/2 days; adm w/c/o fever, nausea, vomiting, diarrhea, hearing loss, ringing in the ears, chills, h/a, HTN;missed 5 days of work stated remained very weak;
Spotting while not on period- post second dose, 2-7 days; dose number: 1 administration date 07Apr2021, dose number: 2 administration date: 24Apr2021; dose number: 1 administration date 07Apr2021, dose number: 2 administration date: 24Apr2021; This is a spontaneous report from a contactable consumer (patient). A 30-year-old Female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Lot number ER8730, on 07Apr2021 13:15 at single dose in left arm, and received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Lot number EW0172, on 24Apr2021 14:00 at single dose in right arm for COVID-19 immunization. Medical history was none. The patient had no allergies. The patient was not diagnosed with COVID-19 Prior to vaccination. The patient had not been tested for COVID-19 Since the vaccination. Concomitant medications included ibuprofen (ADVIL 12 HOUR), caffeine, paracetamol (EXCEDRIN ASPIRIN FREE), melatonin, ethinylestradiol, norethisterone acetate (JUNEL FE 24), and spironolactone. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since 27Apr2021, the patient had Spotting while not on period- post second dose, 2-7 days. No treatment was received. The outcome of the event was resolving.  No follow-up attempts are needed. No further information is expected.
tested positive for COVID three days after getting the booster shot; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (tested positive for COVID three days after getting the booster shot) in a patient of an unknown age and gender who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (tested positive for COVID three days after getting the booster shot). At the time of the report, COVID-19 (tested positive for COVID three days after getting the booster shot) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: Positive.         Concomitant medications were not reported.  No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 06-Nov-2023: Live follow-up received. Reference numbers updated.
Patient reported a red lump formed, hard under the skin, painful and started itching, lasted a full 1 going on 2 weeks.
About 18 hours after Varicella #1 immunization, Pt felt/saw a sore & red spot the size of a quarter. Later in the day, her hands & wrists started itching and she had a rash there which she treated with over the counter Benandryl. At 67 hours after vaccination, there was no rash and approx. 10cm X 7cm wide red, tender, warm, & slightly swollen area where vaccine administrated.  Pt. has Hx of allergy to walnuts & cashews.
Developed persistent productive cough and intermittent runny nose. Sought treatment after two weeks of coughing without improvement. Tested negative for flu, COVID-19, and RSV. Was prescribed doxycycline 2x per day for 10 days, benzonatate 3x per day as needed for cough, and Albuterol every 4 hours as needed for cough. Symptoms mostly resolved, but still experiencing occasional dry cough.
Received Pediarix instead of DTaP and IPV; This case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 2-month-old female patient who received DTPa-HBV-IPV (Pediarix) (batch number X9HS4, expiry date 25th March 2024) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 1st December 2022, the patient received the 2nd dose of Pediarix .5 ml and Pediarix Pre-Filled Syringe Device. On 1st December 2022, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced wrong vaccine administered. On an unknown date, the outcome of the wrong vaccine administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: Reporter's Comments:  The healthcare professionals (Medical Assistant) stated that a patient inadvertently received Pediarix.  The patient was to receive only DTaP, and IPV.  The adverse event was filed. Additional Supportive Information: The patient inadvertently received Pediarix, which led to wrong vaccine administered.
pt recv vax;c/o d & feeling sick for approx a week;md did not feel sx were related to vax;
Pt recvd vax on 2FEB90; Pt returned JUL90 w/ complaint that arm still hurts; Reporter noted no erythema, swelling, tenderness or lump @ inject site, pain in shoulder joint on range of motion referred for eval;
Chills; Fever; Muscle aches; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 26Apr2021 at 10:15 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history (reported as N/A). The patient did not have any known allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 02Apr2021 at 10:15 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. On 27Apr2021 at 02:00, the patient experienced chills, fever, muscle aches and headache. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event chills, fever, muscle aches and headache was resolved on an unknown date in Apr2021.   No follow-up attempts are possible. No further information is expected.
Hive developed immediately at varicella injection site. 5 minutes later also at MMR injection site.
Patient received a PNEUMOMVAX 23 vaccination and was eventually admitted to ER later that night due to intolerable pain in right arm. Patient contacted pharmacy at approximately 12P on 12/1/17 to alert  the pharmacy that she had been admitted to the emergency room due to the pain in her arm following the vaccination. Patient has since been released from ER and is still experiencing pain in right arm but okay now.
SEVERE COLD SYMPTOMS STARTED 12-23 COUGH STARTED 12-25 AND FEVERS STARTED 12-26. WENT TO ER 12-27 AND SWABBED FOR COVID. NEG COVID AND FLU, BUT POSITIVE FOR RSV. NO CHILDREN IN HOUSEHOLD UNDER AGE OF 20
Treatment of COVID-19; Treatment of COVID-19; Pfizer / BioNTech 24Sep2022 / moderna 4Apr2022; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 24Sep2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 73 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 11Feb2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 11Mar2021 as dose 2, single (Batch/Lot number: unknown), in left arm, on 03Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm and on 04Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "bronchiecstasis" (unspecified if ongoing); "known allergies: stone fruits, melons" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 24Sep2022, outcome "unknown", described as "Pfizer / BioNTech 24Sep2022 / moderna 4Apr2022"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: The patient received COVID 19 treatment with Paxlovid from 07Jan2023 to 11Jan2023.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
today HCP is going to vaccinated him with an adult second dose / give Engerix-B adult dose to a 19 year-old male patient today ( April 7th 2021); This case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a 19-year-old male patient who received HBV (Engerix B adult) for prophylaxis.   Previously administered products included Engerix B adult (received 1st dose on 13th August 2019).   On an unknown date, the patient received the 2nd dose of Engerix B adult. On an unknown date, unknown after receiving Engerix B adult, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The physician assistant was looking for information if she could use Engerix B adult dose to the patient.  The patient received his 1st dose 19 months ago and till the time of reporting he did not receive any further doses, which led to incomplete course of vaccination. On the day of reporting, the healthcare professional was going to vaccinated him with the 2nd dose of Engerix B adult. The reporter consented to follow up and requested to follow-up by email.
Flu Shot given 10/03/2016, in afternoon arm was hurting.  On 10/05/2016, arm now hurting into left side of neck.  Employee was advised to go to clinic for evaluation but refused to go to clinic at  9:44 AM on 10/05/2016.
25 year old male patient- after receiving his dose of Janssen he was pale and dizzy. He was taken to the incident observation area  and indicates that it is normal when he has injections. The EMT took his vital signs which were:68 for pulse, 98% for Spo2,110/60 bp and 111 for dextrose. Patient is kept under observation for 30 minutes and vitals signs are taken which are 67 pulse, 95% for SpO2 and 110/20 for bp. Patient reports feeling well and it is recommended he stand up slowly and leave the asymptomatic area and walking.
9-11-06 am patient complain of headache, nausea, sore throat and rash to mom.  Stated rash was "red spots and itchy" child did have "fever" per mom < 50 spots.
This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (The vaccine vas punctured and 5 doses have been given with the following dates and times I am needing information if doses 2, 3, 4, an 5 should be readministered, vaccine stored above 5F frozen was given) and EXPIRED PRODUCT ADMINISTERED (The vaccine vas punctured and 5 doses have been given with the following dates and times I am needing information if doses 2, 3, 4, an 5 should be readministered.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced PRODUCT STORAGE ERROR (The vaccine vas punctured and 5 doses have been given with the following dates and times I am needing information if doses 2, 3, 4, an 5 should be readministered, vaccine stored above 5F frozen was given) and EXPIRED PRODUCT ADMINISTERED (The vaccine vas punctured and 5 doses have been given with the following dates and times I am needing information if doses 2, 3, 4, an 5 should be readministered.). At the time of the report, PRODUCT STORAGE ERROR (The vaccine vas punctured and 5 doses have been given with the following dates and times I am needing information if doses 2, 3, 4, an 5 should be readministered, vaccine stored above 5F frozen was given) and EXPIRED PRODUCT ADMINISTERED (The vaccine vas punctured and 5 doses have been given with the following dates and times I am needing information if doses 2, 3, 4, an 5 should be readministered.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter. Treatment information was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: Action taken, de-challenge and re-challenge was updated
Three days after receiving my second dose I broke out in a rash in the areas of chest, neck, face (including numbness/tingling of lips), arms, legs.  Treated with Benadryl (oral and topical).  I thought this may have been related to possible exposure to a poisonous plant during gardening.  After 5 days with no relief, I contacted my physician.  I received a steroid injection and instructions to take Allegra BID and Benadryl at bedtime.  Now it has been 10 days since the outbreak with no relief and I continue to have more outbreaks occuring on my face, legs and now abdomen.  The rash is extremely itchy.
No adverse events reported while client observed after vaccination.  Received voice message on 4/6 from daughter that client had died several hours after receiving vaccine.  Also reported he had underlying health issues so unsure of cause.  I made telephone call to daughter on 4/6.  Daughter was wanting report made and plans to do so with additional health information included.  I informed daughter I would be making a report also.